Lindbrook Capital, LLC Precision Biosciences Inc Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$2.96 - $7.76 $1,867 - $4,896	-631 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$7.4 - $11.66 $1,332 - $2,098	180 Added 39.91%	631 $5,000
Q4 2020 Jan 27, 2021	BUY	$5.98 - $12.47 $1,979 - $4,127	331 Added 275.83%	451 $4,000
Q3 2020 Nov 03, 2020	BUY	$4.65 - $8.73 $558 - $1,047	120 New	120 $1,000
Q2 2020 Jul 27, 2020	SELL	$4.66 - $8.7 $866 - $1,618	-186 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$5.05 - $15.01 $595 - $1,771	118 Added 173.53%	186 $1,000
Q4 2019 Jan 27, 2020	BUY	$6.32 - $19.66 $429 - $1,336	68 New	68 $1,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $561M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.